Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 14, 2016; 22(10): 2993-3005
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2993
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2993
Figure 3 Kaplan-Meier curve showing an overall 10-year survival.
Overall estimated 1-, 3-, 5-, 7-, and 10-year survival rates are 90.0%, 70.8%, 49.7%, 41.1%, and 28.4%, respectively (n = 234, 181, 136, and 71 for 3, 5, 7, and 10 years, respectively).
- Citation: Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol 2016; 22(10): 2993-3005
- URL: https://www.wjgnet.com/1007-9327/full/v22/i10/2993.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i10.2993